AIRS Medical secures $20 million in Series C funding to advance AI-powered preventive healthcare solutions

AIRS Medical, a pioneer in artificial intelligence (AI) and robotics for healthcare applications, today announced the completion of its Series C financing round and secured 20 million US dollars from seven institutional investors in Korea. The investment, led by BSK Investment and Shinyoung Securities, underscores confidence not only in the company’s flagship product, SwiftMR, but also in its broader mission to revolutionize preventive healthcare through technological innovation.

Also read: Skild AI raises $300 million in Series A to develop a scalable AI foundation model for robotics

The transformation of MRI

SwiftMR™ uses deep learning technology to improve magnetic resonance imaging (MRI) scanning speed by up to 50% compared to standard care.* On average, radiology centers and hospitals that integrate SwiftMR achieve a 38% increase in patient throughput and a 22% reduction in turnaround time, resulting in 44,000 US dollars per month in additional income and a $8,000 Reduction of monthly operating costs.

SwiftMR™ is a solution to reduce scan time with full pulse sequence coverage and true super-resolution. This cutting-edge technology has set the standard in diagnostic imaging and helps overcome critical obstacles faced by radiology centers and hospitals, such as long patient wait times and the knock-on effects of delayed diagnoses.

Improving patient outcomes

A common problem in healthcare is the delayed diagnosis of patients, often when symptoms are already advanced. This, combined with resource constraints, leads to poorer outcomes.

AIRS Medical is paving the way for proactive detection of diseases before they manifest. Through AI and robotics, AIRS Medical is democratizing the best diagnostics and prognosis, reducing the cost and improving the accessibility of MRI scans. This ultimately enables patients with conditions such as dementia, stroke and cancer to receive early diagnoses and improve their chances of better health.

Also read: Deloitte launches AI and data acceleration program with AWS aimed at scaling the next generation of artificial intelligence capabilities

Expanded access to healthcare

In its quest to provide the highest quality healthcare to everyone, AIRS Medical is expanding rapidly. Supported by a talented team, SwiftMR was first launched in Korea in 2021. By 2023, the technology had been successfully adopted. The United States And EuropeMarkets that now account for over half of the company’s annual recurring revenue (ARR).

“We are very pleased with the great support of our investors,” said Hyeseong LeeCEO of AIRS Medical. “This funding will enable us to improve access to preventive healthcare services and create a healthier future for people around the world.”

Building a better future

With this latest round of funding, AIRS Medical is poised to accelerate its growth and innovate beyond the award-winning SwiftMR. The company plans to expand its presence in international markets, invest in research and development, and ultimately improve patient outcomes worldwide.

Also read: Dean Brenner joins Aira’s Advisory Board to accelerate AI-driven RAN modernization

(To share your insights with us as part of editorial or sponsored content, please write to [email protected])